Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT00828594 · TERMINATED
Trial details
- NCT number
- NCT00828594
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2011-06-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.